Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

NCT03288324 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Lupus
Systemic Lupus Erythematosus

Interventions

DRUG: Tofacitinib

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]